Literature DB >> 21556775

STAT3/NF-κB interactions determine the level of haptoglobin expression in male rats exposed to dietary restriction and/or acute phase stimuli.

Aleksandra Uskoković1, Svetlana Dinić, Mirjana Mihailović, Nevena Grdović, Jelena Arambašić, Melita Vidaković, Desanka Bogojević, Svetlana Ivanović-Matić, Vesna Martinović, Miodrag Petrović, Goran Poznanović, Ilijana Grigorov.   

Abstract

Haptoglobin is a constitutively expressed protein which is predominantly synthesized in the liver. During the acute-phase (AP) response haptoglobin is upregulated along with other AP proteins. Its upregulation during the AP response is mediated by cis-trans interactions between the hormone-responsive element (HRE) residing in the haptoglobin gene and inducible transcription factors STAT3 and C/EBP β. In male rats that have been subjected to chronic 50% dietary restriction (DR), the basal haptoglobin serum level is decreased. The aim of this study was to characterize the trans-acting factor(s) responsible for the reduction of haptoglobin expression in male rats subjected to 50% DR for 6 weeks. Protein-DNA interactions between C/EBP and STAT families of transcription factors and the HRE region of the haptoglobin gene were examined in livers of male rats subjected to DR, as well as during the AP response that was induced by turpentine administration. In DR rats, we observed associations between the HRE and C/EBPα/β, STAT5b and NF-κB p50, and the absence of interactions between STAT3 and NF-kB p65. Subsequent induction of the AP response in DR rats by turpentine administration elicited a normal, almost 2-fold increase in the serum haptoglobin level that was accompanied by HRE-binding of C/EBPβ, STAT3/5b and NF-kB p65/p50, and the establishment of interaction between STAT3 and NF-κB p65. These results suggest that STAT3 and NF-κB p65 crosstalk plays a central role while C/EBPβ acquires an accessory role in establishing the level of haptoglobin gene expression in male rats exposed to DR and AP stimuli.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21556775     DOI: 10.1007/s11033-011-0722-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  37 in total

Review 1.  The role of C/EBP in nutrient and hormonal regulation of gene expression.

Authors:  W J Roesler
Journal:  Annu Rev Nutr       Date:  2001       Impact factor: 11.848

2.  Role of CCAAT enhancer-binding protein beta in the thyroid hormone and cAMP induction of phosphoenolpyruvate carboxykinase gene transcription.

Authors:  E A Park; S Song; C Vinson; W J Roesler
Journal:  J Biol Chem       Date:  1999-01-01       Impact factor: 5.157

3.  Protein metabolism after injury with turpentine: a rat model for clinical trauma.

Authors:  M Wusteman; D G Wight; M Elia
Journal:  Am J Physiol       Date:  1990-12

4.  Overexpression of C/EBPbeta-LIP, a naturally occurring, dominant-negative transcription factor, in human breast cancer.

Authors:  C A Zahnow; P Younes; R Laucirica; J M Rosen
Journal:  J Natl Cancer Inst       Date:  1997-12-17       Impact factor: 13.506

5.  Genomic profiling of short- and long-term caloric restriction effects in the liver of aging mice.

Authors:  S X Cao; J M Dhahbi; P L Mote; S R Spindler
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

6.  Essential role of STAT3 in cytokine-driven NF-kappaB-mediated serum amyloid A gene expression.

Authors:  Keisuke Hagihara; Teppei Nishikawa; Yasuhiro Sugamata; Jian Song; Tomoyasu Isobe; Tetsuya Taga; Kazuyuki Yoshizaki
Journal:  Genes Cells       Date:  2005-11       Impact factor: 1.891

7.  Evidence for an alteration of plasma and liver proteins response to dexamethasone in aging rats.

Authors:  I Savary; E Debras; D Dardevet; F Rambourdin; M P Vasson; C Obled; J Grizard
Journal:  Mech Ageing Dev       Date:  2001-01       Impact factor: 5.432

8.  Haptoglobin is synthesized during granulocyte differentiation, stored in specific granules, and released by neutrophils in response to activation.

Authors:  Kim Theilgaard-Mönch; Lars C Jacobsen; Marianne J Nielsen; Thomas Rasmussen; Lene Udby; Maged Gharib; Peter D Arkwright; Adrian F Gombart; Jero Calafat; Søren K Moestrup; Bo T Porse; Niels Borregaard
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

9.  Opposite nuclear level and binding activity of STAT5B and STAT3 proteins with rat haptoglobin gene under normal and turpentine induced acute phase conditions.

Authors:  I Grigorov; T Lazić; I Cvetković; T Milosavljević; M Petrović
Journal:  Mol Biol Rep       Date:  2001       Impact factor: 2.316

10.  Differences between molecular mechanisms involved in the regulation of haptoglobin gene expression during the acute phase response and dietary restriction.

Authors:  A Uskoković; J Arambasić; D Bogojević; S Ivanović-Matić; M Mihailović; S Dinić; I Grigorov
Journal:  Folia Biol (Praha)       Date:  2009       Impact factor: 0.906

View more
  4 in total

1.  Modulation of diabetes-related liver injury by the HMGB1/TLR4 inflammatory pathway.

Authors:  Sofija Jovanović Stojanov; Vesna Martinović; Desanka Bogojević; Goran Poznanović; Anja Petrović; Svetlana Ivanović-Matić; Ilijana Grigorov
Journal:  J Physiol Biochem       Date:  2018-04-02       Impact factor: 4.158

2.  Proximal tubule haptoglobin gene activation is an integral component of the acute kidney injury "stress response".

Authors:  Richard A Zager; Anitha Vijayan; Ali C M Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-09

3.  Liver inflammation and metabolic signaling in ApcMin/+ mice: the role of cachexia progression.

Authors:  Aditi A Narsale; Reilly T Enos; Melissa J Puppa; Saurabh Chatterjee; E Angela Murphy; Raja Fayad; Majorette O' Pena; J Larry Durstine; James A Carson
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

4.  EGF stimulates glioblastoma metastasis by induction of matrix metalloproteinase-9 in an EGFR-dependent mechanism.

Authors:  Xing-Chen Chen; Xiang-Tai Wei; Jun-Hong Guan; Hong Shu; Duo Chen
Journal:  Oncotarget       Date:  2017-07-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.